spinal bone growth

December 5, 2011 -- Yale School of Medicine has chosen the Oregon Evidence-based Practice Center at Oregon Health & Science University as one of two research centers that will independently review all clinical studies of a controversial product used in spinal surgeries to promote bone growth. The selection of the Oregon Evidence-based Practice Center comes after Yale had entered into an unusual agreement with Medtronic, the manufacturer of the bone growth product — called bone morphogenetic protein-2 — to independently review the product.